AntonSkaroMDPhD FRCS(C) FACS

PubMed

• In Reply To: Xue et al. “Developing a Prediction Model for Cardiovascular Risk after Orthotopic Liver Transplantation”
  Lisa B. VanWagner, Hongyan Ning, Maureen Whitsett, Josh Levitsky, Sarah Uttal, John T. Wilkins, Michael Abecassis, Daniela P. Ladner, Anton I. Skaro, Donald M. Lloyd-J...> ;Hepatology. 2017 Sep 16
• Withdrawal of immunosuppression following pediatric liver transplantation: a markov analysis.
  Mohammad S Li Z Englesbe M Skaro A Alonso E> ;J Pediatr Gastroenterol Nutr. 2014 Aug
• Access to retransplantation after failed donation after circulatory death liver transplantation: eo ire itum.
  Skaro AI Zhao L Vanwagner LB Abecassis MM> ;Am J Transplant. 2014 May
• The Extent and Predictors of Waiting Time Geographic Disparity in Kidney Transplantation in the United States.
  Davis AE Mehrotra S McElroy LM Friedewald JJ Skaro AI Lapin B Kang R Holl JL Abecassis MM Ladner DP> ;Transplantation. 2013 Dec 27
• Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.
  Chhabra D Alvarado A Dalal P Leventhal J Wang C Sustento-Reodica N Najafian N Skaro A Levitsky J Mas V Gallon L> ;Am J Transplant. 2013 Nov
• Outcomes and Native Renal Recovery Following Simultaneous Liver-Kidney Transplantation
  T Baker, M L Levin, M M Abecassis, J Friedewald, B Ho, E Wang, S N Ahya, J Levitsky, L Gallon, A Skaro> ;Wiley. 2012 Nov
• Long-Term Kidney Allograft Function and Survival in Prednisone-Free Regimens: tacrolimus/mycophenolate Mofetil Versus tacrolimus/sirolimus
  Darshika Chhabra, Anton I Skaro, Lorenzo Gallon> ;Journal of the American Society of Nephrology.
• A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry.
  Jay C Ladner D Wang E Lyuksemburg V Kang R Chang Y Feinglass J Holl JL Abecassis M Skaro AI> ;J Hepatol. 2011 Oct
• Trends in donation after cardiac death and donation after brain death--reading between the lines.
  Skaro AI Jay CL Ladner D Abecassis MM> ;Am J Transplant. 2010 Nov
• A review of quality of life instruments used in liver transplantation.
  Jay CL Butt Z Ladner DP Skaro AI Abecassis MM> ;J Hepatol. 2009 Nov
• 144 citations
  The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story.
  Anton I. Skaro, Colleen L. Jay, Edward Wang, Sarina Pasricha, Vadim Lyuksemburg, John A. Martin, Joe Feinglass, Luke B. Preczewski, Michael Abecassis, Talia Baker> ;Surgery. 2009 Oct 1
• Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations.
  Tambur AR Ramon DS Kaufman DB Friedewald J Luo X Ho B Skaro A Caicedo J Ladner D Baker T Fryer J Gallon L Miller J Abecassis MM Leventhal J> ;Am J Transplant. 2009 Aug
• Regression of cutaneous and gastrointestinal telangiectasia with sirolimus and aspirin in a patient with hereditary hemorrhagic telangiectasia.
  Skaro AI Marotta PJ McAlister VC> ;Ann Intern Med. 2006 Feb 7
• 8 citations
  Impairment of recipient cytolytic activity attenuates allograft vasculopathy
  Anton I Skaro, Robert S. Liwski, Jennifer O'Neill, Ellen L. Vessie, Juan Zhou, Gregory M. Hirsch, Timothy D.G. Lee> ;Transplant Immunology. 2005 Mar 1
• 16 citations
  CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-γ-dependent indirect pathway
  Anton I Skaro, Robert S. Liwski, Juan Zhou, Ellen L. Vessie, Timothy D.G. Lee, Gregory M. Hirsch> ;Cardiovascular Research. 2005 Jan 1
• Join now to see all